Our Latest News

Tue Feb 20 00:00:00 EST 2018

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

PARIS – February 20, 2018 – Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution. This proprietary technology is currently in early-stage development for total and partial knee replacement, and the Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of orthopaedic surgery procedures.

Mon Jan 29 00:00:00 EST 2018

New Study on Total Hip Arthroplasty (THA) Outcomes with Anterior Approach Show Less Reported Pain, Fewer Narcotics & Better Hip Function in the First 90 Days

JANUARY 24, 2018 Warsaw, Indiana – DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, today announced the first systematic review of prospective studies comparing postoperative outcomes through 90 days of Anterior Approach versus Posterior Approach in primary total hip arthroplasty (THA). The paper, published in The Journal of Arthroplasty, concludes that the Anterior Approach can provide a significant increase in hip function and reduction in pain and narcotics usage compared to Posterior Approach. In addition, the study showed no statistical differences in complication rates between the Anterior Approach and Posterior Approach through 90 days.

Wed Dec 13 00:00:00 EST 2017

DePuy Synthes Announces Financing Options for the Hana® Orthopedic Surgery Table

DECEMBER 13, 2017, Warsaw, Indiana – As an industry leader in the Anterior Approach, today DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies, announced a partnership with Johnson & Johnson Finance Corporation (JJFC) to help healthcare systems accommodate costs associated with the Hana® Orthopedic Surgery Table. The Hana® table allows precise control of patient positioning, manipulation and traction during this minimally invasive hip replacement surgery and provides better access to the hip joint for improved alignment and positioning of the implant.

Wed Dec 06 00:00:00 EST 2017

Next-Generation High-Definition Visualization System for Minimally Invasive Surgery Introduced by DePuy Synthes

Las Vegas, Nev. (Dec. 6, 2017) – Today, the PUREVUE™ Visualization System was unveiled at the Orthopaedic Summit 2017: Evolving Techniques. This new offering from DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, is a state-of-the-art imaging platform for minimally invasive endoscopic surgery.

Thu Nov 02 00:00:00 EDT 2017

Newly Created Johnson & Johnson Institute Will Address Global Needs in Healthcare Professional Education

New Brunswick, NJ (November 2, 2017) – Johnson & Johnson (NYSE: JNJ) today announced that its Family of Companies has formed the Johnson & Johnson Institute to provide comprehensive professional education focused on helping healthcare professionals improve outcomes, increase patient satisfaction and reduce costs in a value based care environment. The curriculum includes on-site classes, virtual reality and app-based surgical simulation training to help clinical and non-clinical healthcare professionals address the demands of today’s health care delivery system in developed as well as emerging markets, such as Brazil and China.

Wed Oct 25 00:00:00 EDT 2017

New DePuy Synthes Spine Technologies Help Simplify Minimally Invasive Surgery by Enhancing Efficiency and Reducing Steps

ORLANDO, Fla. – October 25, 2017 –DePuy Synthes* today is launching two solutions for minimally invasive spinal fusion surgery (MIS) designed to simplify the procedure, particularly as MIS gains traction and shows reduced complications compared to open surgery in treating degenerative disc disease in the back.1,2